Human papillomavirus vaccine initiation among adolescent girls in high-risk communities

Vaccine

Volumn 29, Issue 12, 2011, Pages 2235-2241

  Guerry, Sarah L ^a   De Rosa, Christine J ^b   Markowitz, Lauri E ^c   Walker, Susan ^a   Liddon, Nicole ^c   Kerndt, Peter R ^a   Gottlieb, Sami L ^c  

^a LOS ANGELES COUNTY DEPARTMENT OF PUBLIC HEALTH   (United States)

^b Health Research Association   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Adolescent; HPV vaccine; Human papillomavirus; Immunization

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; AWARENESS; CANCER RISK; CONTROLLED STUDY; FEMALE; HEALTH CARE; HEALTH SURVEY; HIGH RISK PATIENT; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEALTH SURVEYS; HUMANS; IMMUNIZATION PROGRAMS; LOS ANGELES; MALE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; POVERTY AREAS; RISK FACTORS; VACCINATION; YOUNG ADULT;

EID: 79951810768     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.052     Document Type: Article

References (24)

1. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24.
2. Ault K.A. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomized clinical trials. Lancet 2007, 369(9576):1861-1868.
3. Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., Harper D.M., Leodolter S., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007, 356(19):1928-1943.
4. Centers for Disease Control and Prevention FDA licensure of bivalent human papillomavirus vaccine (HPV2, cervarix) for use in females and updated HPV vaccination recommendations from the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(20):626-629.
5. McDougall J.A., Madeleine M.M., Daling J.R., Li C.I. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control 2007, 18:1175-1186.
6. National Cancer Institute. SEER stat fact sheets-cancer of the cervix uteri. Available at: [Last accessed June 23, 2010]. http://seer.cancer.gov/statfacts/html/cervix.html.
7. National Cancer Institute. SEER cancer statistics-fast stats. Available at: [Last accessed June 23, 2010]. http://seer.cancer.gov/faststats/selections.php%23Output.
8. Ethier KA, Chung EQ, DeRosa CJ, Dittus PJ. Project connect: positive effects of a multi-level social-ecological intervention for adolescents. Presented at: 2008 National STD Prevention Conference, Chicago, IL. [Abstract C4].
9. Los Angeles Unified School District Website. Available at: [Last accessed June 23, 2010]. http://www.lausd.net/.
10. Press briefing: ACIP recommends HPV vaccination. Available at: [Last accessed June 23, 2010]. http://www.cdc.gov/media/transcripts/t060629.htm.
11. Santoli J.M., Rodewald L.E., Maes E.F., Battaglia M.P., Coronado V.G. Vaccines for children program, United States, 1997. Pediatrics 1999, 104(2):e15.
12. The American Association for Public Opinion Research Standard definitions: final dispositions of case codes and outcome rates for surveys 2000, AAPOR, Ann Arbor, Michigan.
13. Gottlieb S.L., Brewer N.T., Sternberg M.R., Smith J.S., Ziarnowski K., Liddon N., et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health 2009, 45(5 (October)):430-437.
14. McRee A.L., Brewer N.T., Reiter P.L., Gottlieb S.L., Smith J.S. The carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis 2010, 37(4):234-239.
15. Reiter P.L., Brewer N.T., Gottlieb S.L., McRee A.L., Smith J.S. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009, 69(3 (August)):475-480.
16. Cattell R.B. The scree test for the number of factors. Multivar Behav Res 1966, 1(2):245-276.
17. Centers for Disease Control and Prevention Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep 2008, 57(40 (October)):1100-1103.
18. Grant D, Kravitz-Wirtz N, Breen N, Tiro JA, Tsui J. Health policy research brief: one in four California adolescent girls have had human papillomavirus vaccination. Available at: [Last accessed June 23, 2010]. http://www.healthpolicy.ucla.edu/pubs/files/HPV_PB_0209.pdf.
19. Centers for Disease Control and Prevention National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2008. MMWR Morb Mortal Wkly Rep 2009, 58(36):997-1001.
20. Centers for Disease Control and Prevention National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(32):1018-1023.
21. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a national survey of U.S. physicians 18 months post-licensure. Pediatrics 2010, 126(3):425-433.
22. Arambula and Fletcher, Assembly Bill 354. Chapter 434, Accessible online: [Accessed January 11, 2011]. http://www.leginfo.ca.gov/pub/09-10/bill/asm/ab_0351-0400/ab_354_bill_20100929_chaptered.html.
23. Curtin R., Presser S., Singer E. The effects of response rate changes on the index of consumer sentiment. Public Opin Q 2000, 64:412-428.
24. Keeter S., Miller C., Kohut A., Groves R.M., Presser S. Consequences of reducing nonresponse in a national telephone survey. Public Opin Q 2000, 64:125-148.